Issue of Equity

RNS Number : 6245D
Tristel PLC
20 February 2020
 

 

 

Tristel plc

("Tristel" or the "Company")

Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that, further to the announcement of 18 February 2020 regarding the exercise of options by certain employees, application has been made for the 109,500 new Ordinary Shares issued to be admitted to trading on AIM and dealings are now expected to commence on 24 February 2020, not 21 February as originally anticipated.

The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 44,921,823 Ordinary Shares. Accordingly, the figure of 44,921,823 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact: 

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer


Liz Dixon, Finance Director




Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303



finnCap

Tel: 020 7220 0500

Geoff Nash / Giles Rolls, Corporate Finance


Alice Lane, ECM

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEBBGDDBBDDGGG

Companies

Tristel (TSTL)
UK 100

Latest directors dealings